Theravance Biopharma Balance Sheet - Quarterly (NASDAQ:TBPH)

Add to My Stocks
$27.5 $0.49 (1.81%) TBPH stock closing price Sep 19, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Theravance Biopharma, and helps in stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Theravance Biopharma stock analysis. A company releases its balance sheet every quarter along with its quarterly results. Apart from analyzing Theravance Biopharma revenue Theravance Biopharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Theravance Biopharma balance sheet for 2018 Q2 shows cash on hand of $103.85M. The company has a debt to equity ratio of 6.52.

View and download Theravance Biopharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities249.05M292.7M259.58M243.7M222.19M222.82M156.38M143.91M101.31M51.07M
Raw Materials10.58M10.61M11.72M9.94M6.74M7.44M6.06M7.29M5.81M5.27M
Work In Progress3.35M1.98M--3.38M2.62M2.62M-1.83M1.75M
Finished Goods3.98M4.62M5.03M4.55M1.99M3.14M3.52M4.35M2.16M2.37M
Notes Receivable----------
Other Current Assets7.64M5.32M3.7M3.46M4.03M3.56M2.4M4.31M3.55M10.16M
Total Current Assets
Property Plant & Equipment--56.87M---52.7M---
Accumulated Depreciation--46.71M---44.24M---
Net Property Plant & Equipment
Investment & Advances18.25M16.99M41.58M99.39M144.44M155.88M99.56M66.76M60.31M42.59M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets5.74M5.96M10.9M11M5.88M2.39M2.72M6.65M2.23M1.65M
Total Assets
Notes Payable----------
Accounts Payable3.64M5.08M5.92M5.62M6.4M3.62M1.73M5.35M7.41M9.09M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses35.36M49.93M56.5M43.02M50.55M45.21M47.38M39.84M36.58M36.18M
Income Taxes Payable----------
Other Current Liabilities54.48M50.16M-------1.12M
Total Current Liabilities
Deferred Taxes/Income40.89M51.42M3.66M3.28M3.45M3.67M3.96M4.15M4.36M4.44M
Convertible Debt224.28M224.01M223.74M223.47M223.21M222.94M222.67M---
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities28.33M36.08M36.25M26.49M18.99M18.49M13.11M8.84M3.87M3.73M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus937.44M925.96M913.65M895.22M885.31M871.87M862.7M742.72M732.33M602.11M
Retained Earnings-902.53M-861.7M-797.74M-710.81M-643.94M-577.65M-512.22M-444.89M-410.93M-363.7M
Treasury Stock----------
Other Liabilities-0.53M-0.85M-0.73M-0.29M-0.24M-0.27M-0.25M---
Shareholders Equity34.39M63.4M115.17M184.11M241.12M293.94M350.23M297.87M321.58M238.53M
Total Liabilities & Shareholders Equity421.36M480.1M441.4M486.15M543.88M588.03M639.25M356.28M374.48M293.12M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Theravance Biopharma stock price, and Theravance Biopharma historical stock prices show the stock price movement over time, and the Theravance Biopharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Theravance Biopharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for TBPH stock as of 2018 Q2 is $421.36M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Theravance Biopharma is $386.98M. Shareholders equity comes under liabilities as it is money the company owes the holders of TBPH stock.

Theravance Biopharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio

Quarterly Balance Sheets For Theravance Biopharma Inc Peers

Arrowhead Pharma balance sheet, Merck balance sheet, Pfizer balance sheet